Semi-solid topical composition containing pirfenidone and modified diallyl disulfide oxide (M-DDO) for eliminating or preventing acne
The instant invention relates to a semi-solid topical composition containing Pirfenidone and an antimicrobial/antiseptic agent such as Modified Diallyl Disulfide Oxide (M-DDO) and its preparation process, offering advantages compared to other pharmaceutical forms of topical administration known in the state of the art, useful as antifibrotic, anti-inflammatory and antiseptic agent in the prevention, treatment and reversion of acne and post acne lesions. Said compositions is also useful for reducing skin redness, detaining the formation of new acne outbreaks, reversing already existing outbreaks and regenerating skin damage caused by acne.
1. A method of manufacturing a semi-solid topical composition comprising 1-phenyl-5-methyl-2-(1H)-pyridone (pirfenidone) and {[1,2-diallyl-1-(5-methyl-tetrahydro-2H-pyran-2-yloxy)disulfonium]+6-[(benzyl, methyl, octylammonium)(hydroxymethylamin)(methylamin)]-tetrahydro-2H-pyran-3-oxy]}chloride (M-DDO), the method comprising the steps of:
forming a first solution by combining a viscosity agent and water;
forming a second solution by heating a solubilizer and adding to the solubilizer pirfenidone, a non-ionic solubilizer, and {[1,2-diallyl-1-(5-methyl-tetrahydro-2H-pyran-2-yloxy)disulfonium]+6-[(benzyl, methyl, octylammonium)(hydroxymethylamin)(methylamin)]-tetrahydro-2H-pyran-3-oxy]}chloride (M-DDO);
forming a third solution by combining a neutralizing agent and water; and
adding the second solution and the third solution to the first solution.
2. The method of claim 1 , wherein the step of forming the first solution further comprises leaving the first solution until the viscosity agent is completely moisturized.
3. The method of claim 1 , wherein the step of forming the second solution comprises adding the pirfenidone, the non-ionic solubilizer, and the {[1,2-diallyl-1-(5-methyl-tetrahydro-2H-pyran-2-yloxy)disulfonium]+6-(benzyl, methyl, octylammonium)(hydroxymethylamin)(methylamin)]-tetrahydro-2H-pyran-3-oxy]}chloride (M-DDO) under constant stirring.
4. The method of claim 1 , wherein the step of forming the second solution further comprises maintaining the solubilizer at 40° C. while adding the pirfenidone, the non-ionic solubilizer, and the {[1,2-diallyl-1-(5-methyl-tetrahydro-2H-pyran-2-yloxy)disulfonium]+6-[(benzyl, methyl, octylammonium)(hydroxymethylamin)(methylamin)]-tetrahydro-2H-pyran-3-oxy]}chloride (M-DDO).
5. The method of claim 1 , wherein the step of forming the second solution comprises heating the solubilizer at 40° C.
6. The method of claim 1 , wherein the step of forming the third solution further comprises stirring the neutralizing agent and water until homogeneous.
7. The method of claim 1 , wherein the step of adding the second solution and the third solution further comprises stirring constantly until homogeneous.
8. The method of claim 1 further comprising sampling and analyzing the topical composition.
9. The method of claim 1 , wherein the semi-solid topical composition is in gel, cream, or ointment form.
10. The method of claim 1 , wherein the semi-solid topical composition has a pH of 5 to 6.4.
11. The method of claim 1 , wherein the semi-solid topical composition contains between 2% and 10% pirfenidone by weight.
12. The method of claim 1 , wherein the semi-solid topical composition contains 8% pirfenidone by weight.
13. The method of claim 1 , wherein the viscosity agent is selected from the group consisting of methylcellulose, hydroxypropylcellulose, sodium carboxymethylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymers, carbomers, and acrylic polymers.
14. The method of claim 13 , wherein the viscosity agent is a carbomer.
15. The method of claim 1 , wherein the solubilizer is propylene glycol.
16. The method of claim 1 , wherein the non-ionic solubilizer is macrogol-glycerol hydroxystearate.
17. The method of claim 1 , wherein the neutralizing agent is triethanolamine.
18. The method of claim 1 , wherein the viscosity agent is a carbomer, the solubilizer is propylene glycol, the non-ionic solubilizer is macrogol-glycerol hydroxystearate, and the neutralizing agent is triethanolamine.
19. The method of claim 18 , wherein the semi-solid topical composition contains 50% propylene glycol by weight.
20. The method of claim 18 , wherein the semi-solid topical composition contains 13% macrogol-glycerol hydroxystearate by weight.
21. The method of claim 18 , wherein the semi-solid topical composition contains between 2% and 10% pirfenidone by weight.
22. The method of claim 18 , wherein the semi-solid topical composition contains 8% pirfenidone by weight.
23. The method of claim 1 , wherein the step of forming the first solution comprises combining a viscosity agent and 90% of the total amount of water by weight, and the step of forming the third solution comprises combining a neutralizing agent and 10% of the total amount of water by weight.
24. The method of claim 1 , wherein the semi-solid topical composition contains:
(i) 2%, 4%, 6%, 8%, or 10% pirfenidone by weight;
(ii) 1% carbomer by weight;
(iii) 50% propylene glycol by weight;
(iv) 13% macrogol-glycerol hydroxystearate by weight;
(v) 0.016% {[1,2-diallyl-1-(5-methyl-tetrahydro-2H-pyran-2-yloxy)disulfonium]+6-[(benzyl, methyl, octylammonium)(hydroxymethylamin)(methylamin)]-tetrahydro-2H-pyran-3-oxy]}chloride (M-DDO) by weight;
(vi) 1% triethanolamine by weight; and
(vii) 32.984%, 30.984%, 28.984%, 26.984%, or 24.984% water by weight.